Cargando…

Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential

Cancer cells are under the surveillance of the host immune system. Nevertheless, a number of immunosuppressive mechanisms allow tumors to escape protective responses and impose immune tolerance. Epigenetic alterations are central to cancer cell biology and cancer immune evasion. Accordingly, epigene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maes, Ken, Mondino, Anna, Lasarte, Juan José, Agirre, Xabier, Vanderkerken, Karin, Prosper, Felipe, Breckpot, Karine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042276/ https://www.ncbi.nlm.nih.gov/pubmed/33859645 http://dx.doi.org/10.3389/fimmu.2021.652160

Ejemplares similares

Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma
por: De Beck, Lien, et al.
Publicado: (2022)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022)

Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects
por: De Beck, Lien, et al.
Publicado: (2018)

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma
por: Maes, Ken, et al.
Publicado: (2014)

Explainable artificial intelligence for precision medicine in acute myeloid leukemia
por: Gimeno, Marian, et al.
Publicado: (2022)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
por: Goyvaerts, Cleo, et al.
Publicado: (2018)

Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?
por: Cotton, Sophie, et al.
Publicado: (2012)

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2013)

COBRA methods and metabolic drug targets in cancer
por: Apaolaza, Iñigo, et al.
Publicado: (2017)

Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma
por: Amundarain, Ane, et al.
Publicado: (2022)

Helminth Immunomodulation in Autoimmune Disease
por: Smallwood, Taylor B., et al.
Publicado: (2017)

Epigenetics in Food Allergy and Immunomodulation
por: Cañas, José A., et al.
Publicado: (2021)

Long Non-Coding RNAs in Haematological Malignancies
por: Garitano-Trojaola, Andoni, et al.
Publicado: (2013)

Correction: Ordoñez, et al.; DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters? Cancers 2019, 11, 1424
por: Ordoñez, Raquel, et al.
Publicado: (2020)

DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?
por: Ordoñez, Raquel, et al.
Publicado: (2019)

IDO2 in Immunomodulation and Autoimmune Disease
por: Prendergast, George C., et al.
Publicado: (2014)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
por: Pfeil, Jennifer, et al.
Publicado: (2020)

Editorial: Immunomodulation of Innate Immune Cells
por: Almeida, Catarina R., et al.
Publicado: (2020)

Immunomodulation in the Treatment of Periodontitis: Progress and Perspectives
por: Yang, Bo, et al.
Publicado: (2021)

Editorial: The role of vitamin D as an immunomodulator
por: Aribi, Mourad, et al.
Publicado: (2023)

Cancer-Associated Myeloid Regulatory Cells
por: De Vlaeminck, Yannick, et al.
Publicado: (2016)

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
por: Szabo, Attila
Publicado: (2015)

A Role for Epitope Networking in Immunomodulation by Helminths
por: Homan, E. Jane, et al.
Publicado: (2018)

Immunomodulation by Helminths: Intracellular Pathways and Extracellular Vesicles
por: Zakeri, Amin, et al.
Publicado: (2018)

Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
por: Locy, Hanne, et al.
Publicado: (2018)

Editorial: The Role of Metabolism in MSC-Mediated Immunomodulation
por: Pers, Yves-Marie, et al.
Publicado: (2021)

HP-NAP of Helicobacter pylori: The Power of the Immunomodulation
por: Codolo, Gaia, et al.
Publicado: (2022)

Editorial: Immunomodulation of MSCs in tissue repairing and regeneration
por: Peng, Yanwen, et al.
Publicado: (2023)

Monitoring immunomodulation strategies in type 1 diabetes
por: Krishnamurthy, Balasubramanian, et al.
Publicado: (2023)

Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
por: Héninger, Erika, et al.
Publicado: (2015)

HDAC Inhibitors in Acute Myeloid Leukemia
por: San José-Enériz, Edurne, et al.
Publicado: (2019)

Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
por: Lazarus, Hillard M., et al.
Publicado: (2021)

Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
por: Awad, Robin Maximilian, et al.
Publicado: (2018)

Epigenetic Signatures Associated with Different Levels of Differentiation Potential in Human Stem Cells
por: Aranda, Pablo, et al.
Publicado: (2009)

Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?
por: Plock, Jan A., et al.
Publicado: (2013)

Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes
por: Wiedemann, Marie, et al.
Publicado: (2020)

Innate Immunomodulation in Food Animals: Evidence for Trained Immunity?
por: Byrne, Kristen A., et al.
Publicado: (2020)

Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics
por: Kim, Tae Kang, et al.
Publicado: (2020)

Therapeutic Potential of the Intestinal Microbiota for Immunomodulation of Food Allergies
por: Kreft, Luisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1o72neb9i5tuv7e2k9c2mkhs0j